CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Real-World Experience of Nivolumab in Non-small Cell Lung Cancer in Korea

Sun Min Lim, Sang-We Kim, Byoung Chul Cho, Jin Hyung Kang, Myung-Ju Ahn, Dong-Wan Kim, Young-Chul Kim, Jin Soo Lee, Jong-Seok Lee, Sung Yong Lee, Keon Uk Park, Ho Jung An, Eun Kyung Cho, Tae Won Jang, Bong-Seog Kim, Joo-Hang Kim, Sung Sook Lee, Im-II Na, Seung Soo Yoo, Ki Hyeong Lee

Cancer Research and Treatment. 2020;52(4):1112-1119. Published online 2020 May 15 DOI: https://doi.org/10.4143/crt.2020.245

Real-world data of using durvalumab in stage III non-small cell lung cancer (NSCLC): West Midlands experience

A. Jegannathen

Lung Cancer. 2020;139:S51

Link1 Link2

Real life experience with nivolumab for the treatment of non-small cell lung carcinoma

Robert D. Schouten, Mirte Muller, Cornedine J. de Gooijer, Paul Baas, Michel van den Heuvel

Lung Cancer. 2018;126:210-216

Link1 Link2

Correction to: Multicenter Real-World Study on Effectiveness and Early Discontinuation Predictors in Patients With Non-small Cell Lung Cancer Receiving Nivolumab

The Oncologist. 2022;

Link1

Link2

Real world efficacy of nivolumab for non-small cell lung cancer (NSCLC) in the West of Scotland (WoS)

S. Ansel, R. Rulach, B. Clark, N. Steele, V. Maclaren

Lung Cancer. 2018;115:S35-S36

Link1 Link2

Real‐world experience of nivolumab in the treatment of poor performance status patients with advanced non‐small cell lung cancer

M. Nazim Abbas, Myron Klevansky, Bogda Koczwara, Amitesh Chandra Roy, Shawgi Sukumaran, Sina Vatandoust, Christos Stelios Karapetis

Cancer Reports. 2021;5(3):

Link1 Link2 Link3

Real world experience of immunotherapy in elderly patients with advanced non-small cell lung carcinoma: a retrospective study

M. Tilby, H.C. Ghanta, A. Jain

Lung Cancer. 2020;139:S54

Link1 Link2

The use of second or third line nivolumab in advanced non-small cell lung cancer: a west of Scotland experience

C. Ali, K. Yahya

Lung Cancer. 2018;115:S31

Link1 Link2

Real world treatment and outcomes in patients with EGFR mutation positive advanced non-small cell lung cancer: the Kent Cancer Network experience

V. Angelis, M. Fenton, S. Hunter, R. Shah

Lung Cancer. 2019;127:S39

Link1 Link2

The real-world experience with nivolumab in previously treated patients with advanced non-small cell lung cancer from a cancer center in India

Waseem Abbas, Rudra Prasad Acharya, Archit Pandit, Saurabh Gupta, Ranga Raju Rao

South Asian Journal of Cancer. 2020;09(01):50-52

Link1

A real-world experience of immune checkpoint inhibitors: immunotherapy related adverse events for locally advanced and metastatic non-small cell lung cancer

L. Sidon, M. Dillon, D. Power, S. Dubash

Lung Cancer. 2020;139:S49

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.